£1.6M
The company will apply its machine learning technology to improve the production of oligonucleotide therapeutics in partnership with CPI.
Intellegens builds machine learning software to accelerate research and development processes.
Cambridge-based Intellegens provides machine learning software designed to help industrial research and development teams make sense of sparse data.

Ben Pellegrini
CEO
Ben is the chief executive officer and co-founder of Intellegens. His background includes roles as chief technology officer at CambridgeIP and senior software engineer at the Eastern Cancer Registry and Information Centre.
LinkedIn
The company will apply its machine learning technology to improve the production of oligonucleotide therapeutics in partnership with CPI.